Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adductor Canal Block vs Lumbar Plexus Block for Post-Op Knee Pain
NCT01818531Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Apr 2013
- Primary completion
- May 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Verbal Pain Scores at 6 Hours Post Nerve Blockade. Started Apr 2013; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01818531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01818531.